Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT04892667
Eligibility Criteria:
Inclusion Criteria:
* Patients of at least 18 years of age, treated as part of an initial extension assessment (staging) of a lymphoma (Hodgkin's or non-Hodgkin's)
* Treatment with a chemotherapy protocol containing Anthracyclines (ABVD protocol, enhanced BEACOPP, R CHOP, CHOP, CHOEP, EPOCH, ACVBP)
* Signed informed consent
* Affiliation to a social security system (AME excepted)
Exclusion Criteria:
* FEVG\<53%
* Cardiological symptomatic patient (Dyspnea, angina, palpitations, syncope, left ventricular insufficiency, right ventricular insufficiency, overall heart failure)
* Patient for whom PET/CT invalidates the presence of lymphoma (Hodgkin's or non-Hodgkin's)Uncontrolled blood pressure (AP) (systolic AP \> 140 mm Hg and/or diastolic AP \> 90 mmHg)
* Myocardial infarction in the 3 months prior to inclusion
* Heart failure in the 3 months prior to inclusion
* Severe symptomatic or asymptomatic mitral valvulopathy
* Symptomatic or asymptomatic tight aortic stenosis
* Atrial Fibrillation
* Pregnant or lactating woman
* Hypersensitivity to 18F-FDG
* Patient under guardianship or curatorship
* Patient under State Medical Aid
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04892667
Study Brief:
Protocol Section:
NCT04892667